Wird geladen...
Targeting rtPA in acute ischemic stroke based on risk of intracranial hemorrhage or poor functional outcome: an analysis of the IST-3 trial
BACKGROUND AND PURPOSE: Intravenous rtPA, despite a risk of early symptomatic intracranial hemorrhage (SICH), is of net clinical benefit to acute stroke patients. We tested if predictive models could identify patients least likely to be harmed by SICH or those who gained no net benefit. METHODS: We...
Gespeichert in:
| Veröffentlicht in: | Stroke |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2014
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4282175/ https://ncbi.nlm.nih.gov/pubmed/24603072 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.113.004362 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|